AKT1 and cancer: Due to its privileged structure, the thiazole ring can interact with multiple molecular targets relevant to cancer therapy [70], such as EGFR kinase inhibition [71], Akt (PKB) protein kinases inhibition [72], topoisomerase inhibition [73], and inhibition of tubulin polymerization [74].